Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
G04BE08	TALYS	G	Tadalafil - 5mg	5mg	Tablet, film coated	1,574,216 L.L
G04BE08	TYRA	G	Tadalafil - 5mg	5mg	Tablet, film coated	3,566,558 L.L
G04BE08	VIVIDA 5	G	Tadalafil - 5mg	5mg	Tablet, film coated	2,559,700 L.L
G04BE08	APO-TADALAFIL	G	Tadalafil - 10mg	10mg	Tablet	888,280 L.L
G04BE08	DURALIS	G	Tadalafil - 10mg	10mg	Tablet, film coated	1,187,701 L.L
G04BE08	TADALAFIL BIOGARAN	G	Tadalafil - 10mg	10mg	Tablet, coated	1,397,596 L.L
G04BE08	AMOS	G	Tadalafil - 20mg	20mg	Film, orodispersible	2,175,745 L.L
G04BE08	AMOS	G	Tadalafil - 10mg	10mg	Film, orodispersible	1,662,781 L.L
G04BE08	AMOS	G	Tadalafil - 5mg	5mg	Film, orodispersible	2,743,998 L.L
G04BE09	LEVITRA	B	Vardenafil (HCl) - 20mg	20mg	Tablet, film coated	2,660,808 L.L
G04BE09	LEVIDOR	G	Vardenafil (HCl) - 20mg	20mg	Tablet	401,809 L.L
G04BE09	VERDA	G	Vardenafil (HCl) - 10mg	10mg	Tablet, orally disintegrating	1,023,880 L.L
G04BE09	LEVIDOR	G	Vardenafil (HCl) - 5mg	5mg	Tablet	876,185 L.L
G04BE30	LIF-DOL	B	Yohimbin HCl - 3.3mg, Thiamine - 5.5mg, Cyanocobalamine - 0.015mg, Ferrous fumarate - 50mg, Sildenafil citrate - 10mg		Tablet, coated	231,653 L.L
G04BX	ROWATINEX	B	Olive oil - 33mg, Cineol - 3mg, Fenchone - 4mg, Anethol - 4mg, Borneol - 10mg, Camphene - 15mg, ?-Pinene - 6.2mg, ?-Pinene - 24.8mg		Capsule	255,330 L.L
G04BX14	PRILIGY	B	Dapoxetine (hydrochloride) - 30mg	30mg	Tablet, film coated	1,957,979 L.L
G04BX14	DEPOJOY	G	Dapoxetine (hydrochloride) - 30mg	30mg	Tablet, film coated	1,565,577 L.L
G04BX14	LEJAM	G	Dapoxetine (hydrochloride) - 30mg	30mg	Tablet, film coated	1,269,931 L.L
G04BX14	PRIXETIN 30	G	Dapoxetine (hydrochloride) - 30mg	30mg	Tablet, film coated	2,105,353 L.L
G04BX14	PRILIGY	B	Dapoxetine (hydrochloride) - 60mg	60mg	Tablet, film coated	1,957,979 L.L
G04BX14	DEPOJOY	G	Dapoxetine (hydrochloride) - 60mg	60mg	Tablet, film coated	1,565,577 L.L
G04BX14	PRIXETIN 60	G	Dapoxetine (hydrochloride) - 60mg		Tablet, film coated	1,479,123 L.L
G04CA01	XATRAL XL	B	Alfuzosin HCl - 10mg	10mg	Tablet, prolonged release	1,061,636 L.L
G04CA01	ALFOCIN	G	Alfuzosin HCl - 10mg	10mg	Tablet, extended release	858,779 L.L
G04CA01	ALFUZOSINE BIOGARAN LP	G	Alfuzosin HCl - 10mg	10mg	Tablet, coated, prolonged release	1,115,389 L.L
G04CA01	APO-ALFUZOSIN	G	Alfuzosin HCl - 10mg	10mg	Tablet	2,331,567 L.L
G04CA01	PROSTETROL	G	Alfuzosin HCl - 10mg	10mg	Tablet, modified release	360,150 L.L
G04CA01	PROSTETROL	G	Alfuzosin HCl - 10mg	10mg	Tablet, modified release	682,672 L.L
G04CA02	OMNIC OCAS	B	Tamsulosin HCl - 0.4mg	0.4mg	Tablet, film coated, prolonged release	866,778 L.L
G04CA02	APO-TAMSULOSIN CR	G	Tamsulosin HCl - 0.4mg	0.4mg	Tablet	607,417 L.L